Enlicotide: Lowering LDL Cholesterol in Familial Hypercholesterolemia
New Drug Enlicitide Demonstrates Significant LDL Cholesterol Reduction in Familial Hypercholesterolemia Groundbreaking research reveals that the investigational drug enlicitide has shown remarkable efficacy in lowering low-density lipoprotein (LDL) cholesterol levels, particularly in individuals with familial hypercholesteremia (FH), a genetic condition characterized by dangerously high cholesterol. The findings, presented in recent reports, offer a potential new … Read more